The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.75
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.50 (7.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 20.75
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

9 Aug 2011 07:00

RNS Number : 9809L
Iofina PLC
09 August 2011
 



 

 

9 August 2011

 

 

Iofina plc

("Iofina" or "the Group")

 

Trading Update

 

The Board of Iofina (LSE AIM: IOF), the holding company of a group of companies involved in the exploration and production of iodine, water and natural gas, is pleased to announce a continuation of the growth experienced towards the end of the last financial year. Overall revenues in the first half of the current financial year are ahead of the same period last year at USD$9.6 million and since April 2011 the Group has been cash flow positive.

 

Highlights:

 

·; Iofina's mid-stream third party iodine collection and extraction business continues to gain new sites and increased capacity

·; End user agreement secured to purchase 100,000 barrels per day (BPD) of water in both Montana and North Dakota for industrial use

·; Atlantis field anticipated to be back on line in Q2 2012 with Joint Venture ("JV") partner

·; Iodine prices continue to surge with recent spot pricing near $100 a kilogram

 

Iofina Chemical

In the first half of the year sales at the Group's iodine derivatives manufacturer, Iofina Chemical, were strong representing the highest six month revenue performance in the Group's history. Profit margins have improved with EBITDA of USD$1.3 million (2010: EBITDA of USD$1.01 million). At the present time, the order book and outlook for the second half of the year is encouraging.

 

Third party iodine collection

At Iofina's West Coast Operations in California, design and engineering was completed for installation at the facility to take the full c.30,000 BPD brine stream at the Warren location. The initial design was successfully modified to meet the operator's unexpected requirements of restricted space. The Board anticipates completion of installation by calendar year end. Modification was made to the existing WET® unit to maximize throughput to increase iodine production from 5,000 BPD to 8,500 BPD. During the construction period the Group will continue to extract iodine with the existing WET® POD.

 

At Iofina's Southwest Operations in Texas, we are adding a flocculation process to pre-treat the water, where such enhanced pre-treatment will enable us to improve the collection of iodine due to the chemistry of the brine at this location. We expect to increase current production to 8,500 BPD in Q3 2011.

 

At Iofina's central operations in Wyoming, initial results from the new Pilot WET® POD are highly encouraging. The pre-treated water coming to the POD is contributing significantly to our recovery with reduced chemical costs due to less pre-treatment of the brine stream. We plan to continue to increase production through Q3 2011 to take the full capacity of the brine stream.

 

Iofina continues to collect large volumes of iodine rich brine samples from numerous sites around North America - particularly in California, Texas, Saskatchewan, Louisiana and Oklahoma. Large volumes of iodine rich brine are being found which presents Iofina with ample locations to place WET® PODs.

 

Water treatment

Iofina is especially pleased to have secured in the past week an end-user agreement to purchase 100,000 BPD of water in both Montana and North Dakota for industrial use. The Board is currently finalising a JV agreement with a strategic blue chip partner to cover water rights developmental costs, water treatment facilities, water out take depots, and development drilling at Atlantis. This agreement, if concluded, is likely to have a positive impact on the Group's second half of the year.

 

Outlook

The Board remains focused to increase production by year-end to an annualized rate of c.250MT of iodine with its existing contracts, while also developing new growth opportunities. The Atlantis field is also anticipated to be back on line in Q2 2012 with our JV partner. Furthermore, the proposed water treatment arrangement with our JV partner will, once concluded, enable Iofina to create a new revenue stream and enter into a market that management believes can be highly lucrative as the water division develops.

 

Iofina Natural Gas will be exhibiting the Group's acreage position in Northern Montana at the NAPE Expo, the world's largest E&P (upstream) expo, from 17 - 19 August 2011. Our objective is to obtain a partner interested in pursuing the deeper oil shale plays (Bakken and Three Forks) while Iofina retains the shallow rights (Eagle and Virgelle) which make up the Atlantis field - a concept often found in the Oil & Gas industry. The Board believes that, given the large contiguous acreage position of in excess of 200,000 acres, and comprehensive data, it will attract a prospective partner enabling a further monetization of its own Atlantis acreage.

 

Following the nuclear tragedy in Japan, there has never been a more important time for iodine producing companies. Iodine prices continue to surge with recent spot pricing near $100 a kilogram. Iofina believes iodine prices will remain high for the foreseeable future as demand is currently outstripping declining supply.

 

 

For further information, please contact:

 

Lance Baller, CEO

Iofina plc

Tel: +44(0)20 3006 3135

 

Nominated Adviser:

James Harris/Angela Peace

Strand Hanson Limited

Tel: +44(0)20 7409 3494

 

Joint Broker:

Rory Scott

Mirabaud Securities Limited

Tel: +44(0)20 7878 3360

 

 

Media Contact:

Dominic Barretto

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

Joint Broker:

Richard Morrison

Matt Einhorn

Klara Kaczmarek

Ambrian Partners Limited

Tel: +44(0)20 7634 4700

 

 

 

About Iofina

Iofina is involved in the exploration and production of iodine, produced water and natural gas with complete vertical integration into the specialty chemical iodine derivatives business. It also provides third party brine stream operators with a turnkey mid stream fee based solution to extract iodine. The presence of both iodine and natural gas has been discovered on acreages which the Company holds through its wholly owned subsidiary Iofina Natural Gas, Inc. The presence of iodine, produced water and natural gas allows the Group to generate three revenue streams over a single cost structure.

 

Iofina is traded on the London Stock Exchange's AIM Market under the ticker: IOF

www.Iofina.com 

 

Wellhead Extraction Technology® and WET® are registered trademarks of Iofina Natural Gas, Inc.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVDTEITIIL
Date   Source Headline
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating
9th May 20237:00 amRNSNotice of AGM
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20234:45 pmRNSHolding(s) in Company
28th Apr 20237:00 amRNSGrant of Share Options
25th Apr 20237:00 amRNS2022 FULL YEAR RESULTS
12th Apr 20237:00 amRNSProduction Update
20th Feb 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSMarket Update
28th Dec 20222:34 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIofina Chemical Awarded ISO Certification
21st Nov 20227:00 amRNSChange of Adviser
28th Oct 20227:00 amRNSFinalised Terms for IO9 & Q3 Production Update
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSInterim Results
8th Jul 20227:00 amRNSAdditional Loan Facilities and H1 Update
5th Jul 20228:54 amRNSHolding(s) in Company
22nd Jun 20222:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSAppointment of Chrystal Capital Partners LLP
27th May 20227:00 amRNSNotice of AGM
26th May 20224:15 pmRNSHolding(s) in Company
26th May 20222:15 pmRNSHolding(s) in Company
24th May 20226:15 pmRNSHolding(s) in Company
20th May 20227:10 amRNSInvestor Presentation
18th May 20227:00 amRNSHolding(s) in Company
9th May 20227:00 amRNSFinal Results
5th May 20227:00 amRNSHolding(s) in Company
28th Apr 20228:38 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 and IO#9 Update
8th Apr 20221:07 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSGrant of Share Options
8th Mar 20228:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.